Organovo Holdings, Inc.
ONVO
Peringkat dalam Saham
#36082
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
Harga Saham
$2.00
Terakhir disinkronkan: 2025-05-19
Kapitalisasi Pasar
$2.93M
Perubahan (1 hari)
-3.38%
Perubahan (1 tahun)
656.14%
Negara
US
Perdagangan Organovo Holdings, Inc. (ONVO)
Kategori
Healthcare
Kapitalisasi pasar dari Organovo Holdings, Inc.(ONVO)
Kapitalisasi Pasar: $2.93M
Per October 2026, Organovo Holdings, Inc. memiliki kapitalisasi pasar sebesar $2.93M. Ini menjadikan Organovo Holdings, Inc. sebagai perusahaan 36082nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Organovo Holdings, Inc. dari 2014 hingga 2026
ONVO dibandingkan dengan 5 teratas stocks paling populer
